Abdullahi Bello

Mr. Abdullahi Bello


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2020 in SN Applied Sciences
Verified
Journal Article
Open access
PDF file
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
SK-MEL-5 is a human melanoma cell line that has been used in several researches to explore new therapies against melanoma. Based on this study we report on the development of quantitative structure–activity relationship (QSAR) model and molecular docking simulation able to predict the cytotoxic effect of diverse chemical compounds on this cancer cell line. The dataset of seventy-two (72) cytotoxic compounds were downloaded from the National Cancer Institute database. It contains the data of compounds for which cytotoxicity results expressed by pGI50 was recorded. The QSAR model was built using fifty (50) compounds and the best-generated model based on multiple linear regression showed, respectively good quality of fits [\(R^{2}\) (0.864), \(R_{adjusted}^{2}\) (0.846), Q2cv (0.841) and \(R_{pred}^{2}\) (0.885)]. The model’s predictive ability was determined by a test set of twenty-two (22) compounds and the applicability domain was assessed through leveraged approach. Compounds 41 and 69 were selected as templates for in silico design because they had high pGI50 activity and are within the model’s applicability domain. The obtained information from the model was explored to design novel compounds by introducing various substituents. Moreover, the designed compounds were docked into the active site of the protein (PDB CODE: 3OG7) which is responsible for melanoma cancer to elucidate their binding mode. Ia (− 12.4 kcal mol−1) and IIb (− 12.3 kcal mol−1) showed a better binding affinity for the target when compared with (vemurafenib, − 11.3 kcal mol−1) the known inhibitor of the target (V600E-BRAF). These results may be of great help in early anticancer drug discovery.

1 March 2020 in Heliyon
Verified
Journal Article
Open access
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
A dataset of seventy-two (72) cytotoxic compounds of the National Cancer Institute (NCI) was studied by QSAR and docking approaches to gain deeper insights into ligands selectivity on SK-MEL-2 cell line. The QSAR model was built using fifty (50) molecules and the best-generated model based on multiple linear regression showed, respectively good quality of fits ( R 2 (0.864), R a d j u s t e d 2 (0.845), Q2 cv (0.799) and R p r e d 2 (0.706)). The model's predictive ability was determined by a test set of twenty-two (22) compounds. Compounds 30 and 41 were selected as templates for in silico design because they had high pGI50 activity and are in the model's applicability domain. The obtained information from the model was explored to design novel molecules by introducing various modifications. Moreover, the designed compounds with better-predicted activity (pGI50) values were selected and docked on the active site of the protein (PDB-CODE: 3OG7) which is responsible for melanoma cancer to elucidate their binding mode. AN2 (-12.1kcalmol-1) and AC4 (-12.4kcalmol-1) showed a better binding score for the target when compared with (vemurafenib, -11.3kcalmol-1) the known inhibitor of the target (V600E-BRAF). These findings may be very helpful in early anti-cancer drug development.

31 March 2020 in European Journal of Chemistry
Verified
Journal Article
Open access
PDF file
MAMustapha Abdullahi
Mustapha Abdullahi
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
DADavid Arthur
David Arthur
ABAbdullahi Bello
Abdullahi Bello
MIMuhammad Tukur Ibrahim
Muhammad Tukur Ibrahim
A virtual docking simulation study was performed on thirty-five newly discovered compounds of N-(2-phenoxy) ethyl imidazo[1,2-a] pyridine-3-carboxamide (IPA), to explore their theoretical binding energy and pose with the active sites of the Mycobacterium tuberculosis target (DNA gyrase). The chemical structures of the compounds were drawn correctly with ChemDraw Ultra software, and then geometrically optimized at DFT level of theory with Spartan 14 software package. Consequently, the docking analysis was carried out using Molegro Virtual Docker (MVD). Five complexes (Complex 5, 24, 25, 33 and 35) with high binding energy were selected to examine their binding pose with the active sites of the protein. The docking results suggested a good MolDock score (≥ -90 kcal/mol) and Protein-Ligand ANT System (PLANTS) score (≥ -60 kcal/mol) which depicted that the compounds can efficiently bind with the active sites of the target. However, compound 5 has the best binding pose with the MolDock score of -140.476 kcal/mol which formed three hydrogen bond interactions with the Gln 538, Ala 531, and Ala 533 amino acid residues. This research gives a firsthand theoretical knowledge to improve the binding efficiency of these compounds with the target.

12 September 2019 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Closed access
PDF file
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
USUba Sani
Uba Sani

4 February 2023 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
ABAbdullahi Bello
Abdullahi Bello
AUAdamu Uzairu
Adamu Uzairu
V600E-BRAF kinase is an essential therapeutic target in melanoma and other types of tumors. Because of its resistance to known inhibitors and the adverse effects of some identified inhibitors, investigation of new potent inhibitors is necessary. In the present work, in silico strategies such as molecular docking simulation, pharmacokinetic evaluation, and density functional theory (DFT) computations were used to identify potential V600E-BRAF inhibitors from a set of 72 anticancer compounds in the PubChem database. Five top-ranked molecules (12, 15, 30, 31, and 35) with excellent docking scores (MolDock score ≥90 kcal mol-1, Rerank score ≥60 kcal mol-1) were selected. Several potential binding interactions were discovered between the molecules and V600E-BRAF. The formation of H-bonds and hydrophobic interactions with essential residues of V600E-BRAF suggested the high stability of these complexes. The selected compounds had excellent pharmacological properties according to the drug likeness rules (bioavailability) and pharmacokinetic properties. Similarly, the energy for the frontier molecular orbitals, such as the HOMO, LUMO, energy gap, and other reactivity parameters, was computed with DFT. The frontier molecular orbital surfaces and electrostatic potentials were investigated to demonstrate the charge-density distributions potentially associated with anticancer activity. The identified compounds were found to be potent hit compounds for V600E-BRAF inhibition with superior pharmacokinetic properties; therefore, they may be promising cancer drug candidates.

23 January 2023 in Chemistry Africa
Verified
Journal Article
Closed access
PDF file
SASagiru Hamza Abdullahi
Sagiru Hamza Abdullahi
AUAdamu Uzairu
Adamu Uzairu
GSGideon Adamu Shallangwa
Gideon Adamu Shallangwa
SUSani Uba
Sani Uba
ABAbdullahi Bello
Abdullahi Bello